🔗 Visit the ClinicalTrials.gov page for NCT01477749
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Dendritic cell-based interventions for cancer therapy. | Oncoimmunology | 2012 | 1.51 |
| 2 | Perspectives on treatment of metastatic castration-resistant prostate cancer. | Oncologist | 2013 | 1.42 |
| 3 | Antigen-specific vaccines for cancer treatment. | Hum Vaccin Immunother | 2014 | 0.89 |
| 4 | Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy. | Cancer Immunol Immunother | 2015 | 0.82 |